Ophthalmic Products Manufacturers
In India
Get in Touch
Eyes are among the most delicate and vital organs of the human body, yet they are constantly exposed to dust, pollution, and digital screens. Over the past decade, the demand for advanced ophthalmic medicines has grown rapidly, leading to the rise of several trusted ophthalmic products manufacturers in India. These manufacturers play a key role in providing safe, sterile, and effective eye care solutions to millions of patients across the globe.
From basic lubricating eye drops to complex anti-glaucoma formulations, the Indian pharmaceutical industry has achieved international recognition for quality, innovation, and affordability. Modern ophthalmic pharma companies in India combine advanced R&D, automation, and strict quality standards to produce world-class eye care products that meet diverse therapeutic needs.
Understanding Ophthalmic Medicines
Ophthalmic medicines are specialized pharmaceutical formulations designed to treat eye-related disorders. These include eye drops and ophthalmic suspensions, all manufactured under strictly sterile conditions. A reliable eye drops manufacturer in India ensures that each formulation provides accurate dosage, maintains appropriate pH balance, and guarantees patient comfort.
Some of the most common types of ophthalmic formulations are:
Lubricating Eye Drops
Relieve dryness, redness, and irritation.
Antibiotic Eye Drops
Treat bacterial infections such as conjunctivitis.
Anti-Allergic Eye Drops
Manage itching and burning caused by allergens.
Anti-Inflammatory Drops
Reduce inflammation after eye surgeries or infections.
Anti-Glaucoma Drops
Help control intraocular pressure and prevent vision loss.
All these formulations are produced by professional Ophthalmic Products Manufacturers in India who follow WHO-GMP and ISO-certified processes to ensure the highest quality and sterility.
Eye Drops Products List
| Table Header | Table Header | Table Header | Table Header |
|---|---|---|---|
|
Content |
Content |
Content |
Content |
| S.no | Molecule Name | Category | Strength Variations | Commercial aspect |
|---|---|---|---|---|
| 1 | Carboxymethyl Cellulose Sodium | Lubrication / Dry Eyes | 0.5% - 1% | Mass molecule |
| 2 | HPMC | Lubrication / Dry Eyes | 0.30% | Mass molecule |
| 3 | Polyvinyl Alcohol | Lubrication / Dry Eyes.1.4% | 3.0% | Mass molecule |
| 4 | Sodium Hyaluronate | Lubrication / Dry Eyes | 0.1% - 0.18% (10 ml) | d premium |
| 5 | Polyethylene Glycol & Propylene Glycol | Lubrication / Dry Eyes | 0.40% | Mass molecule |
| 6 | Sodium Hyaluronate +Polyethylene Glycol & Propylene Glycol | Lubrication / Dry Eyes | - | New molecule |
| 7 | Sodium Chloride | Lubrication / Dry Eyes | 5.00% | Mass molecule |
| 8 | Alcaftadine | Anti-Allergy / Itching | 0.25% | Less exposure in domestic |
| 9 | Azelastine | Anti-Allergy / Itching | 0.05% | Less exposure in domestic |
| 10 | Bepotastine | Anti-Allergy / Itching | 1.50% | Premium |
| 11 | Olopatadine | Anti-Allergy / Itching | 0.1% - 0.2% - 0.5% - 1.0% | Mass molecule (0.7% new addition) |
| 12 | Ketorolac Tromethamine | Anti-Allergy / Inflammation | 0.4% - 0.5% & Dexamethasone Phosphate | Mid premium |
| 13 | Loteprednol | Anti-Allergy / Inflammation | 0.2% - 0.5% | Mid premium |
| 14 | Moxifloxacin & Ketorolac | Anti-Allergy / Inflammation | 0.5% Moxifloxacin & 0.5% Ketorolac | Mass molecule |
| 15 | Moxifloxacin & Loteprednol | Anti-Allergy / Inflammation | 0.5% Moxifloxacin & 0.5% Loteprednol | Mid premium |
| 16 | Moxifloxacin & Bromfenac | Anti-Allergy / Inflammation | 0.5% Moxifloxacin & 0.09% Bromfenac | Mid premium |
| 17 | Moxifloxacin 0.5% & Dexamethasone 0.1% | Anti-Allergy / Inflammation | 0.5% Moxifloxacin & 0.1% Dexamethasone | Mass molecule |
| 18 | Moxifloxacin 0.5% & Prednisolone Acetate 1 % Eye Drop 5 ml | Anti-Allergy / Inflammation | 0.5% Moxifloxacin & 1% Prednisolone | Mid premium |
| 19 | Azithromycin & Dexamethasone | Anti-Allergy / Inflammation | - | Mid premium |
| 20 | Cromolyn Sodium Ophthalmic Solution | Anti-Allergy / Inflammation | 1% | Premium |
| 21 | Fluconazole Eye Drops | Anti-fungal | 0.35% | Mid premium |
| 22 | Fluorometholone & Neomycin Sulphate | Cortecosteroid + Antibiotic | 0.1% - 0.35% | Mid premium |
| 23 | Fluorometholone & Gentamicin | Cortecosteroid + Antibiotic | 0.1% - 0.3% | Mid premium |
| 24 | Fluorometholone Eye Drops | Cortecosteroid | 0.10% | Mass molecule |
| 25 | Gatifloxacin & Ketorolac Tromethamine | Anti-Allergy / Inflammation | 0.3% - 0.4% | Mid premium |
| 26 | Gatifloxacin & Loteprednol | Anti-Allergy / Inflammation | 0.3% - 0.5% | Mid premium |
| 27 | Gatifloxacin & Prednisolone | Anti-Allergy / Inflammation | 0.3% - 1% | Mid premium |
| 28 | Gatifloxacin 3 mg & Dexamethasone 1 mg Eye Drops | Anti-Allergy / Inflammation | - | Mass molecule |
| 29 | Gatifloxacin 3 mg & Flurbiprofen 0.3 mg Ophthalmic Solution | Anti-Allergy / Inflammation | - | New molecule |
| 30 | Gatifloxacin 3.0 mg & Difluprednate 0.5 mg Eye Drops | Anti-Allergy / Inflammation | - | New molecule |
| 31 | Ofloxacin & Dexamethasone | Anti-Allergy / Inflammation | 0.3% - 0.1% | Mass molecule |
| 32 | Levofloxacin 1.5% & Loteprednol Etabonate 0.5% Eye Drops | Anti-Allergy / Inflammation | - | Premium |
| 33 | Levofloxacin 1.5% & Prednisolone Acetate 1.0% Eye Drops 5 ml | Anti-Allergy / Inflammation | - | Mid premium |
| 34 | Levofloxacin Ophthalmic Solution 0.5 % w/v | Anti-Allergy / Inflammation | - | Mass molecule |
| 35 | Tobramycin & Dexamethasone | Anti-Allergy / Inflammation | 0.3% - 0.05% | Mass molecule |
| 36 | Potassium Iodide 3.3% - Calcium Chloride 1.0% & Sodium Chloride 0.83% Ophthalmic Solution | Cataract | - | Mid premium |
| 37 | Lomefloxacin | Anti-Allergy / Itching | 3 mg/ml | Scoping to be done |
| 38 | Cyclosporin | Anti-Allergy / Inflammation | 0.05% - 0.1% | Mid premium |
| 39 | Betaxolol | Glaucoma / IOP Reduction | 0.25% - 0.5% | Premium |
| 40 | Latanoprost | Glaucoma / IOP Reduction | 0.01% | Premium |
| 41 | Bimatoprost & Timolol | Glaucoma / IOP Reduction | Combination (strengths vary) | Premium |
| 42 | Bimatoprost | Glaucoma / IOP Reduction | 0.01% - 0.03% | Premium |
| 43 | Brimonidine tartarate | Glaucoma / IOP Reduction | 0.15% - 0.2% | Premium |
| 44 | Brimonidine tartarate & Timolol | Glaucoma / IOP Reduction | 0.2% - 0.5% | Premium |
| 45 | Brinzolamide & Timolol | Glaucoma / IOP Reduction | 1.0% & 0.5% - 2.0% & 0.5% variants | Premium |
| 46 | Brinzolamide & Brimonidine Tartrate | - | 1% - 0.2% | Premium |
| 47 | Dorzolamide & Timolol | Glaucoma / IOP Reduction | 0.2% - 2.0% & 0.5% variants | Premium |
| 48 | Travoprost & Timolol | Glaucoma / IOP Reduction | 0.004% & 0.5 mg | Premium |
| 49 | Timolol | Glaucoma / IOP Reduction | 0.5% & 5 mg | Mid premium |
| 50 | Timolol Maleate 5 mg and Hydroxypropylmethylcellulose 3 mg Eye Drops | - | - | New molecule |
| 51 | Prednisolone Acetate | Anti-Inflammatory | 1% - 10 mg (equivalent) various formulations | Mid premium |
| 52 | Bromfenac Sodium Ophthalmic Solution | Post surgery pain/ inflammation | 0.09% | Mid premium |
| 53 | Nepafenac Ophthalmic Suspension | Anti-Inflammatory | 0.10% | Mass molecule |
| 54 | Dexamethasone | Anti-Inflammatory | 0.1% - 0.1% & 0.05% | Mass molecule |
| 55 | Flurbiprofen | Anti-Inflammatory | 0.03% - 0.3% | Scoping to be done |
| 56 | Ciprofloxacin & Dexamethasone | Anti-Microbial / Infections | 0.3% & 0.1% or 0.05% variants | Mass molecule |
| 57 | Ofloxacin & Dexamethasone | Anti-Microbial / Infections | 0.3% & 0.1% - 0.05% | Mid premium |
| 58 | Tobramycin & Fluorometholone | Anti-Microbial / Infections | - | Premium |
| 59 | Besifloxacin Ophthalmic Suspension | Anti-Bacterial | 0.60% | Premium |
| 60 | Chloramphenicol and Flurbiprofen | Anti-Bacterial | 0.5% - 0.03% | Premium |
| 61 | Ciprofloxacin & Dexamethasone | Steroids | 0.3% - 0.1% | Mass molecule |
| 62 | Tropicamide Eye Drops | Pupil dialation | 0.50% | Mass molecule |
Every ophthalmic formulation requires precision manufacturing and contamination-free production. That’s why ophthalmic products manufacturers in India invest in advanced facilities equipped with automated filling lines, HEPA filtration systems, and microbiological testing labs to ensure product purity and consistency.
The Growing Demand for Ophthalmic Products
With increased awareness of eye health, urbanization, and extended screen usage, India has become one of the leading global hubs for ophthalmic product manufacturing. The country’s strong pharmaceutical base and skilled workforce have fueled the rise of ophthalmic products manufacturers in India that are capable of producing both domestic and export-grade formulations.
Additionally, the growing export market has made third party ophthalmic manufacturing a major contributor to the Indian pharma sector. Many multinational brands collaborate with Indian manufacturers to source affordable yet high-quality ophthalmic products that comply with global regulatory standards.
As a result, Indian ophthalmic medicine manufacturers have become trusted partners for pharmaceutical brands across Asia, Africa, and Latin America.
Key Trends Shaping the Ophthalmic Industry
The ophthalmic sector in India is evolving rapidly due to advancements in research, technology, and packaging innovation. Some of the key trends include:
Preservative-Free Formulations:
Modern ophthalmic products manufacturers in India are focusing on preservative-free multi-dose systems to ensure longer shelf life and improved patient safety.Combination Therapies:
Advanced dual-action formulations such as Bimatoprost + Timolol provide more effective glaucoma management by combining two active ingredients in a single drop.Smart Packaging:
Automated and sterile packaging systems, adopted by leading eye drops manufacturers in India, help prevent contamination and ensure precision dosing.Global Contract Manufacturing:
India has become a preferred destination for third party ophthalmic manufacturers offering export-quality products at competitive rates.Research-Driven Development:
Increased investment in R&D has led to innovative molecules, improved ocular absorption, and enhanced patient comfort.
These developments prove that ophthalmic pharma companies in India are setting new global benchmarks in both technology and therapeutic quality.
Manufacturing Excellence in Ophthalmic Products
Producing ophthalmic formulations requires accuracy, expertise, and strict adherence to sterile manufacturing guidelines. Reputed ophthalmic medicine manufacturers in India maintain facilities with:
Automatic filling and sealing machines
Controlled temperature and humidity systems
In-house analytical and microbiological labs
Each production stage—from raw material selection to packaging—is monitored through a robust quality assurance process. Every batch undergoes sterility, clarity, and pH testing before release.
Because of these stringent practices, Indian ophthalmic products manufacturers have earned credibility in highly regulated markets such as the UK, South Africa, and the Middle East.
ophthalmic products manufacturers in india
Popular Ophthalmic Products Manufacturers in India
Some of the most widely used ophthalmic formulations produced by Indian manufacturers include:
Polyethylene Glycol and Propylene Glycol Eye Drops
For long-lasting relief from dryness, irritation, and digital eye strain.
Carboxymethylcellulose Sodium Eye Drops
For soothing dryness and irritation.
Bimatoprost Ophthalmic Solution
For lowering elevated intraocular pressure and managing glaucoma effectively.
Azithromycin and Dexamethasone Ophthalmic Solution
For treating bacterial eye infections and reducing inflammation effectively.
These products highlight India’s ability to deliver safe, effective, and affordable ophthalmic solutions across multiple therapeutic categories.
Why India Leads the Global Ophthalmic Manufacturing Market
India’s dominance in ophthalmic manufacturing is the result of strong infrastructure, affordable production costs, and a highly skilled scientific workforce. The country’s Ophthalmic Products Manufacturers in India follow WHO-GMP, ISO, and GLP certifications to maintain world-class quality.
The growing popularity of ophthalmic products manufacturers in India has also helped international brands launch their private-label products efficiently. This collaborative ecosystem has positioned India as a trusted partner for global ophthalmic development, making it a leader in innovation and affordability.
Maya Biotech Pvt. Ltd. – A Trusted Partner in Ophthalmic Manufacturing
Among the most reputable names in the industry, Maya Biotech Pvt. Ltd. stands out as a leading ophthalmic products manufacturer in India. Known for its dedication to quality and innovation, the company specializes in producing a wide range of ophthalmic formulations including anti-allergic, antibiotic, anti-glaucoma, and lubricating eye drops.
Every product at Maya Biotech is developed under WHO-GMP-certified sterile environments, ensuring purity and patient safety. As a premier third party Ophthalmic Products Manufacturers in India, Maya Biotech offers complete support — from formulation development and packaging design to documentation and export compliance.
Through advanced R&D, cutting-edge manufacturing facilities, and a focus on client satisfaction, Maya Biotech continues to strengthen India’s position as a global hub for ophthalmic excellence.
